Recommended or mandatory pertussis vaccination policy in developed countries: does the choice matter?

Authors:
Address: University of Nantes, Institut d'Economie et de Management - IAE, LEMNA, Chemin de la Censive du Tertre, BP 52241, 44322 Nantes Cedex 03, France. dorota.girard@univ-nantes.fr
Journal:

Publication:

abstract

OBJECTIVES:

To compare universal Recommended and compulsory pertussis vaccination strategies in developed countries, and to discuss their effectiveness in terms of the proportion of infants and children who complete their primary course of pertussis vaccine.

STUDY DESIGN:

Retrospective analysis.

METHOD:

National pertussis surveillance and vaccination coverage data, official pertussis vaccination recommendations, and medical and epidemiological sources related to the use, safety and efficacy of whole-cell and acellular vaccines were analysed.

RESULTS:

Similar vaccine coverage rates among children (above 94%) can be achieved at national level regardless of the type of vaccination legislation in place. mandatory and recommended vaccination strategies appear to be equally effective.

CONCLUSIONS:

The choice of vaccination strategy is based on the national history of pertussis infection, the safety of available whole-cell vaccines and the willingness of health authorities to introduce acellular vaccines into routine use. The strategies adopted in the UK and the USA are two contrasting examples of immunization policies developed on the basis of different epidemiological backgrounds. They attest to the various associations between the type of pertussis vaccine and the type of universal vaccination strategies that can be undertaken for successful pertussis control. The introduction of a mandatory policy generally takes place during a period of low vaccination coverage, and is vindicated by the need for a rapid increase in immunization uptake. Countries that have already succeeded in implementing sustainable and high rates of uptake with a voluntary approach are expected to recommend pertussis vaccination, considering this to be the most justifiable policy.

Related Articles
Review Which strategy for pertussis vaccination today?
Paediatr Drugs. 2002
Review Which strategy for pertussis vaccination today?
Girard DZ. Paediatr Drugs. 2002; 4(5):299-313.
Review Control of pertussis in the world.
World Health Stat Q. 1992
Review Control of pertussis in the world.
Galazka A. World Health Stat Q. 1992; 45(2-3):238-47.
Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
CMAJ. 2006
Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D, Ross AG, Mainar-Jaime RC, Neudorf C, Shah S. CMAJ. 2006 Nov 7; 175(10):1213-7.
The epidemiology of pertussis in Germany: past and present.
BMC Infect Dis. 2009
The epidemiology of pertussis in Germany: past and present.
Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, Wirsing von König CH, Reiter S. BMC Infect Dis. 2009 Feb 25; 9:22. Epub 2009 Feb 25.
Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.
Eur J Pediatr. 1998
Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.
Tormans G, Van Doorslaer E, van Damme P, Clara R, Schmitt HJ. Eur J Pediatr. 1998 May; 157(5):395-401.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.